Rabacfosadine Succinate
Generic Name: rabacfosadine succinate
Dosage form: INJECTION, POWDER, FOR SOLUTION. Active ingredients: RABACFOSADINE SUCCINATE (16.4 mg/mL). Category: DRUG FOR FURTHER PROCESSING.
Overview
Dosage form: INJECTION, POWDER, FOR SOLUTION. Active ingredients: RABACFOSADINE SUCCINATE (16.4 mg/mL). Category: DRUG FOR FURTHER PROCESSING.
Dosage
Available as injection, powder, for solution.
Related Medications
Mycophenilic Acid
mycophenilic acid
Antimetabolite Immunosuppressant [EPC]
11 DESCRIPTION Mycophenolic acid delayed-release tablets, USP are an enteric formulation of mycophenolate sodium that delivers the active moiety mycophenolic acid (MPA). Mycophenolic acid is an immunosuppressive agent. As the sodium salt, MPA is chemically designated as (E)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydroisobenzofuran-5-yl)-4-methylhex-4-enoic acid sodium salt. Its empirical formula is C 17 H 19 O 6 Na.
Toxicodendron Diversilobum Leaf, Toxicodendron Pubescens Leaf, Toxicodendron Vernix Leafy Twig, Urtica Dioica, Semecarpus Anacardium Juice, Graphite, Daphne Mezereum Bark, Urtica Urens, Xerophyllum Asphodeloides
toxicodendron diversilobum leaf, toxicodendron pubescens leaf, toxicodendron vernix leafy twig, urtica dioica, semecarpus anacardium juice, graphite, daphne mezereum bark, urtica urens, xerophyllum asphodeloides
USES : Temporarily relieves occasional skin irritation.**
Obecabtagene Autoleucel
obecabtagene autoleucel
11 DESCRIPTION AUCATZYL (obecabtagene autoleucel) is a CD19-directed genetically modified autologous Tcell immunotherapy comprised of the patient's T cells that are transduced with a lentiviral vector to express an anti-CD19 chimeric antigen receptor (CAR). The CAR is composed of a murine anti-CD19 single chain variable fragment (scFv) linked to 4-1BB and CD3-zeta co-stimulatory domains.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.